Lokivetmab in Dogs

Lokivetmab is the generic name for Cytopoint, a prescription injection used in dogs to reduce itching linked to allergic dermatitis and atopic dermatitis. It is not a cure for the underlying allergy. Instead, it helps interrupt the itch cycle so the skin has a better chance to recover while your vet works on the bigger picture, such as flea control, infection treatment, diet trials, bathing plans, or allergy testing when needed.

This medication is only labeled for dogs. It is commonly used for dogs with environmental allergies, but your vet may also consider it when itch is part of a more complicated skin case. Cornell notes that canine atopic dermatitis is common and often needs a combination approach over time, not one single treatment forever. That is why lokivetmab is often one piece of a longer-term skin plan rather than the whole plan by itself.

For many pet parents, one of the biggest advantages is convenience. Lokivetmab is given as an injection under the skin, usually at the clinic, and many dogs receive it about every 4 to 8 weeks depending on response. That can be helpful for dogs who resist pills, have stomach sensitivity, or need itch control without a daily medication routine.

Because itchy skin can also be caused by fleas, food reactions, mites, yeast, bacteria, or other diseases, your vet still needs to confirm what problem they are treating. If your dog has severe redness, open sores, ear infections, facial swelling, trouble breathing, or sudden worsening after any medication, see your vet immediately.

Lokivetmab is a monoclonal antibody, which means it is a lab-made protein designed to target one very specific signal in the body. In this case, it binds to canine interleukin-31, often shortened to IL-31. IL-31 is one of the main itch messengers involved in sending the sensation of itch from inflamed skin toward the nervous system. By neutralizing that signal, lokivetmab helps reduce scratching, licking, chewing, and rubbing.

This targeted action is different from broader medications that suppress larger parts of the immune response. Merck Veterinary Manual lists lokivetmab as a fast-onset option for both acute flares and longer-term management of canine atopic dermatitis, with improvement often starting within 1 to 3 days. VCA also notes that effects are usually seen within 1 to 2 days, although every dog responds a little differently.

Because it mainly targets itch signaling, lokivetmab does not directly treat secondary skin infections, fleas, food allergy, or the environmental trigger itself. A dog may feel less itchy but still need ear medication, antibiotics, antifungals, parasite control, or a diet trial. That is one reason your vet may pair Cytopoint with other treatments rather than relying on it alone.

For pet parents, the practical takeaway is that lokivetmab can be a focused anti-itch tool. It may help break the scratch-damage-inflammation cycle, but it works best when your vet also addresses the cause of the flare and any complications already present in the skin or ears.

Lokivetmab is generally considered well tolerated in dogs, but side effects can still happen. Reported effects include vomiting, diarrhea, decreased appetite, low energy or sleepiness, and soreness at the injection site. PetMD also notes that some dogs may limp briefly if the injection site is tender. Merck lists lethargy and vomiting among the more common adverse effects reported with this medication.

Skin and ear issues can still show up while a dog is receiving Cytopoint. VCA notes that skin redness and ear infections were occasionally seen in safety studies. That does not always mean the medication caused the problem. Many dogs receiving lokivetmab already have allergic skin disease, and those dogs are prone to secondary infections. Your vet will help sort out whether a new symptom is part of the allergy itself, a flare, or a medication reaction.

Rarely, dogs can have a hypersensitivity reaction or anaphylaxis. Warning signs include facial swelling, hives, sudden vomiting, collapse, or trouble breathing. See your vet immediately if any of those happen after an injection. VCA also notes that sensitivity can develop over time, so a dog that tolerated earlier doses can still react later.

It is also worth remembering that less scratching does not always mean the skin is fully healthy. If your dog still has odor, greasy skin, red paws, recurrent ear debris, or open sores, follow up with your vet even if the itch seems better. Those signs may point to infection or another problem that needs separate treatment.

Lokivetmab is given by subcutaneous injection, meaning it is injected under the skin. The labeled dose is weight-based, and Merck lists lokivetmab at 2 mg/kg subcutaneously every 2 to 8 weeks. In everyday practice, many dogs receive it about every 4 to 8 weeks, but the exact interval depends on how long relief lasts for that individual dog and what else is going on with the skin.

Your vet usually gives the injection in the clinic. PetMD states that Cytopoint is prescription-only and typically administered at a veterinary practice, where your vet can diagnose the cause of itch, choose the correct dose, and monitor response. VCA notes that if it is given during a vaccine visit, it should be injected at a different body site than the vaccines.

There is no one-size-fits-all schedule. Some dogs need repeat injections close to every month during heavy allergy seasons, while others can go longer between doses. If the medication seems to wear off sooner than expected, tell your vet. That may mean your dog needs a different interval, added skin support, or a workup for infection, fleas, food allergy, or another trigger.

If you miss a scheduled injection, contact your vet rather than doubling up or trying to improvise. Your vet may recommend giving the next dose as soon as possible and then adjusting the schedule from there. Dogs with chronic allergy often do best when rechecks are based on both itch control and skin health, not itch alone.

Documented drug interactions with lokivetmab are limited, and VCA states there are no documented drug interactions for this medication. In safety studies, dogs received a range of other products without obvious added problems, including parasiticides, antibiotics, antifungals, antidepressants, antiemetics, corticosteroids, NSAIDs, vaccines, immunotherapy, antihistamines, and other antipruritic medications.

That said, limited documented interactions does not mean every combination is right for every dog. Dogs with severe skin disease often take several medications at once, and the full treatment plan still needs review by your vet. Combining therapies may be reasonable when a dog has infection, ear disease, flea allergy, or a major flare, but the safest mix depends on age, medical history, and what diagnosis your vet is treating.

Vaccination timing is one practical point to discuss. VCA advises that if lokivetmab is given at the same visit as vaccines, it should be injected at a different site on the body. This is more of an administration consideration than a known harmful interaction, but it is still useful for monitoring any local reactions.

Be sure your vet knows about everything your dog receives, including supplements, over-the-counter products, medicated shampoos, allergy chews, and herbal products. If your dog is pregnant, nursing, or intended for breeding, bring that up too, because VCA notes safety has not been established in pregnant or nursing dogs.